Skip to main content

Published locations for FDA approves alirocumab, first injectable lipid-lowering biologic therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves alirocumab, first injectable lipid-lowering biologic therapy

User login

  • Reset your password
  • /content/fda-approves-alirocumab-first-injectable-lipid-lowering-biologic-therapy
  • /familypracticenews/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first-injectable-lipid
  • /internalmedicinenews/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first-injectable
  • /clinicalendocrinologynews/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first
  • /ecardiologynews/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first-injectable-lipid
  • /cardiology/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first-injectable-lipid
  • /endocrinology/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first-injectable-lipid
  • /internalmedicine/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first-injectable-lipid
  • /familymedicine/article/101511/cad-atherosclerosis/fda-approves-alirocumab-first-injectable-lipid